Vinod Chandran
Professor
Oncology
University of Toronto
Canada
Biography
Vinod Chandran M.B., B.S., M.D., D.M., Ph.D. Associate Professor Contact information University Health Network 399 Bathurst St., Rm 1-416 East Wing Toronto Ontario M5T 2S8 Phone: 416-603-5192 Fax: 416-603-9387 Email: vinod.chandran@uhnresearch.ca Research location: Toronto Western Hospital/Research Institute (UHN) Primary Research Area: Genetics, Genomics & Proteomics Secondary Research Area: Infectious Diseases & Immunopathology Research Statement: Dr. Chandran’s research expertise is in the area of translational research involving the identification of soluble biomarkers. His bench research aims to identify mechanisms underlying inflammation and joint damage. His program aims to address the current gaps in disease assessment such as early diagnosis and prognostication to prevent joint damage and development of tools to facilitate efficient management of psoriatic arthritis. Vinod Chandran M.B., B.S., M.D., D.M., Ph.D. Associate Professor Contact information University Health Network 399 Bathurst St., Rm 1-416 East Wing Toronto Ontario M5T 2S8 Phone: 416-603-5192 Fax: 416-603-9387 Email: vinod.chandran@uhnresearch.ca Research location: Toronto Western Hospital/Research Institute (UHN) Primary Research Area: Genetics, Genomics & Proteomics Secondary Research Area: Infectious Diseases & Immunopathology Research Statement: Dr. Chandran’s research expertise is in the area of translational research involving the identification of soluble biomarkers. His bench research aims to identify mechanisms underlying inflammation and joint damage. His program aims to address the current gaps in disease assessment such as early diagnosis and prognostication to prevent joint damage and development of tools to facilitate efficient management of psoriatic arthritis.
Research Interest
Dr. Chandran’s research expertise is in the area of translational research involving the identification of soluble biomarkers. His bench research aims to identify mechanisms underlying inflammation and joint damage. His program aims to address the current gaps in disease assessment such as early diagnosis and prognostication to prevent joint damage and development of tools to facilitate efficient management of psoriatic arthritis.
